Regulatory Informatics Reveals Minimal Residual Disease Trends in Hematologic Malignancies
Conclusion:
The application of informatics tools to regulatory science can evaluate the role and context of MRD as it evolves in the changing pharmaceutical landscape.
Source: Therapeutic Innovation and Regulatory Science - Category: Drugs & Pharmacology Authors: Rach, E. A., Kalra, S., Williams, T., Hung, H.-L. Tags: Regulatory Science Source Type: research
More News: Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Clinical Trials | Drugs & Pharmacology | Health | Hematology | Leukemia | Science | Statistics | Study | Workshops